{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:31:29Z","timestamp":1791235889294,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T00:00:00Z","timestamp":1408320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103200","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T15:30:17Z","timestamp":1408375817000},"page":"e103200","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and Day 7 Plasma Piperaquine Concentrations in African Children Treated for Uncomplicated Malaria with Dihydroartemisinin-Piperaquine"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"isrctn59761234","registry":"10.18810\/isrctn"}],"author":[{"given":"Issaka","family":"Zongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice A.","family":"Som\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge A. M.","family":"Somda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Rouamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Lindegardh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Bosco","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,18]]},"reference":[{"key":"ref1","article-title":"Guidelines for the treatment of malaria, second edition","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(05)66417-3","article-title":"Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial","volume":"365","author":"TK Mutabingwa","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pctr.0010007","article-title":"Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda","volume":"1","author":"H Bukirwa","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(07)60236-0","article-title":"Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial","volume":"369","author":"I Zongo","year":"2007","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1001\/jama.297.20.2210","article-title":"Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial","volume":"297","author":"G Dorsey","year":"2007","journal-title":"Jama"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(02)12021-6","article-title":"Sulfadoxine\/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial","volume":"360","author":"G Dorsey","year":"2002","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(06)68931-9","article-title":"Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison","volume":"367","author":"F Smithuis","year":"2006","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e2390","DOI":"10.1371\/journal.pone.0002390","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda","volume":"3","author":"A Yeka","year":"2008","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1086\/522985","article-title":"Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso","volume":"45","author":"I Zongo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.00955-07","article-title":"Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand","volume":"52","author":"J Tarning","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00195-09","article-title":"Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria","volume":"53","author":"J Tarning","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2875-8-58","article-title":"Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria","volume":"8","author":"J Gutman","year":"2009","journal-title":"Malar J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.01187-09","article-title":"New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine","volume":"54","author":"S Krudsood","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.00040-06","article-title":"Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria","volume":"50","author":"EA Ashley","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1128\/AAC.05136-11","article-title":"Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria","volume":"55","author":"S Salman","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/AAC.05067-11","article-title":"Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria","volume":"55","author":"MJ Rijken","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/AAC.01242-12","article-title":"Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy","author":"JCP Tarning","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2011.254","article-title":"Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria","volume":"91","author":"J Tarning","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/infdis\/jit078","article-title":"Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants","volume":"207","author":"DJ Creek","year":"2013","journal-title":"J Infect Dis"},{"key":"ref20","article-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","year":"2003"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpba.2005.10.027","article-title":"Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine","volume":"41","author":"J Tarning","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","article-title":"Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa","volume":"52","author":"CV Plowe","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4269\/ajtmh.2006.75.836","article-title":"Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections","volume":"75","author":"B Greenhouse","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.49.12.5127-5128.2005","article-title":"Pitfalls in estimating piperaquine elimination","volume":"49","author":"J Tarning","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","article-title":"Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial","volume":"4","author":"Q Bassat","year":"2009","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.trstmh.2006.01.001","article-title":"Safety and efficacy of dihydroartemisinin\/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children","volume":"100","author":"C Karema","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/647946","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children","volume":"49","author":"E Arinaitwe","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref28","first-page":"CD005564","article-title":"Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria","author":"AA Omari","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-10-50","article-title":"Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children","volume":"10","author":"M Nambozi","year":"2011","journal-title":"Malar J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","article-title":"Piperaquine: a resurgent antimalarial drug","volume":"65","author":"TM Davis","year":"2005","journal-title":"Drugs"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/AAC.02306-12","article-title":"In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes","volume":"57","author":"M Hao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/AAC.01304-09","article-title":"Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007","volume":"54","author":"P Lim","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.01412-09","article-title":"In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda","volume":"54","author":"SL Nsobya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso","volume":"54","author":"AF Some","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1475-2875-8-272","article-title":"Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children","volume":"8","author":"S Katrak","year":"2009","journal-title":"Malar J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/344647","article-title":"Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria","volume":"35","author":"MB Denis","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T23:09:09Z","timestamp":1565737749000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103200"}},"subtitle":[],"editor":[{"given":"Steffen","family":"Borrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,18]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103200","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,18]]}}}